Adagene Inc. Files 6-K for FY 2024 Results
Ticker: ADAG · Form: 6-K · Filed: Mar 24, 2025 · CIK: 1818838
| Field | Detail |
|---|---|
| Company | Adagene INC. (ADAG) |
| Form Type | 6-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, business-update, sec-filing
TL;DR
Adagene dropped its FY24 results via 6-K on 3/24. Check the press release for deets.
AI Summary
Adagene Inc. filed a Form 6-K on March 24, 2025, reporting its full-year 2024 financial results and providing a business update. The filing includes a press release detailing these results and updates on the company's operations and strategic direction.
Why It Matters
This filing provides investors with the latest financial performance and operational updates from Adagene Inc., crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial results filing and does not introduce new risks.
Key Players & Entities
- Adagene Inc. (company) — Registrant
- Peter Luo (person) — Chief Executive Officer
- March 24, 2025 (date) — Filing date
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K filing reports Adagene Inc.'s full-year 2024 financial results and provides a business update, as detailed in an accompanying press release.
Who signed this report on behalf of Adagene Inc.?
Peter Luo, Chief Executive Officer, signed the report on behalf of Adagene Inc.
What is the filing date of this report?
This report was filed on March 24, 2025.
What is the principal executive office address for Adagene Inc.?
The principal executive offices are located at 4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu Province, 215123, People's Republic of China.
Which exhibit is included with this Form 6-K filing?
Exhibit 99.1 is included, which is a Press Release titled 'Adagene Reports Full Year 2024 Financial Results and Provi'.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 24, 2025 by Peter Luo regarding Adagene Inc. (ADAG).